Last reviewed · How we verify

heme iron polypeptide

Milton S. Hershey Medical Center · FDA-approved active Small molecule Quality 1/100

heme iron polypeptide is a Small molecule drug developed by Milton S. Hershey Medical Center. It is currently FDA-approved. Also known as: Proferrin, HIP.

At a glance

Generic nameheme iron polypeptide
Also known asProferrin, HIP
SponsorMilton S. Hershey Medical Center
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about heme iron polypeptide

What is heme iron polypeptide?

heme iron polypeptide is a Small molecule drug developed by Milton S. Hershey Medical Center.

Who makes heme iron polypeptide?

heme iron polypeptide is developed and marketed by Milton S. Hershey Medical Center (see full Milton S. Hershey Medical Center pipeline at /company/milton-s-hershey-medical-center).

Is heme iron polypeptide also known as anything else?

heme iron polypeptide is also known as Proferrin, HIP.

What development phase is heme iron polypeptide in?

heme iron polypeptide is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing